IFLScience on MSN12h
The Pope Has Double Pneumonia – Here’s What That Means
Pneumonia is an infection of the lungs that can be caused most commonly by bacteria or viruses, such as Streptococcus ...
Novel inhalable gene therapy trialed for people with cystic fibrosis
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
precisionmedicineonline13h
Boehringer Ingelheim Kicks Off Inhaled Cystic Fibrosis Gene Therapy Phase I/II Trial With Partners
Boehringer Ingelheim, IP Group, UK Respiratory Gene Therapy Consortium, and OXB launched the first-in-human clinical trial, known as LENTICLAIR 1.
News Medical on MSN17h
New discovery offers hope in the battle against pulmonary fibrosis
A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe.
A 3D lung model raises the bar for research
Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depends on the ...